期刊文献+

Effects of Panax Notoginoside on the Nephropathy in Rats with Type 1 Diabetes Mellitus 被引量:6

Effects of Panax Notoginoside on the Nephropathy in Rats with Type 1 Diabetes Mellitus
原文传递
导出
摘要 Objective:To explore the effects and underlying mechanisms of Panax notoginoside(PNS) on the nephropathy in rats with type 1 diabetes.Methods:A murine model of diabetic nephropathy was set up by an intravenous injection of streptozotocin(STZ).Wistar rats were randomly divided into 5 groups:the control group, the diabetic group(DM),the group treated with low-dosage PNS(PNS-L),the group treated with high-dosage PNS(PNS-H) and the group treated with catopril.Rats in the PNS-L and PNS-H groups were given different dosages of PNS while rats in the catopril group were given catopril through gastrogavage every day for the next four consecutive weeks.Serum creatinine(Cr) levels,endogenous creatinine clearance rate(CCr),and 24-h urinary microalbumin(UAlb) were examined and calculated.Meanwhile,immunohistochemistry was applied to determine the expression of vascular endothelial growth factor(VEGF) and bone morphogenetic protein-7 (BMP-7) in the kidney tissue.Results:The levels of Cr,Ccr,and UAlb were all elevated significantly in the DM group(P0.01).The expression of VEGF protein was increased but BMP-7 protein was decreased in the kidney tissue(P0.01).However,the above items decreased in the PNS-L,PNS-H and catopril groups compared with the DM group(P0.05,P0.01).In the PNS-L,PNS-H and catopril groups,the expression of VEGF protein was decreased but BMP-7 protein was increased in the kidney tissue(P0.05,P0.01).Conclusion:PNS shows protective effects on the kidney in type 1 diabetic rats at the early stage.The protective mechanism might be closely related to its role of inhibiting the expression of VEGF protein and enhancing the expression of BMP-7 protein in the kidney. Objective:To explore the effects and underlying mechanisms of Panax notoginoside(PNS) on the nephropathy in rats with type 1 diabetes.Methods:A murine model of diabetic nephropathy was set up by an intravenous injection of streptozotocin(STZ).Wistar rats were randomly divided into 5 groups:the control group, the diabetic group(DM),the group treated with low-dosage PNS(PNS-L),the group treated with high-dosage PNS(PNS-H) and the group treated with catopril.Rats in the PNS-L and PNS-H groups were given different dosages of PNS while rats in the catopril group were given catopril through gastrogavage every day for the next four consecutive weeks.Serum creatinine(Cr) levels,endogenous creatinine clearance rate(CCr),and 24-h urinary microalbumin(UAlb) were examined and calculated.Meanwhile,immunohistochemistry was applied to determine the expression of vascular endothelial growth factor(VEGF) and bone morphogenetic protein-7 (BMP-7) in the kidney tissue.Results:The levels of Cr,Ccr,and UAlb were all elevated significantly in the DM group(P0.01).The expression of VEGF protein was increased but BMP-7 protein was decreased in the kidney tissue(P0.01).However,the above items decreased in the PNS-L,PNS-H and catopril groups compared with the DM group(P0.05,P0.01).In the PNS-L,PNS-H and catopril groups,the expression of VEGF protein was decreased but BMP-7 protein was increased in the kidney tissue(P0.05,P0.01).Conclusion:PNS shows protective effects on the kidney in type 1 diabetic rats at the early stage.The protective mechanism might be closely related to its role of inhibiting the expression of VEGF protein and enhancing the expression of BMP-7 protein in the kidney.
出处 《Chinese Journal of Integrative Medicine》 SCIE CAS 2011年第8期612-615,共4页 中国结合医学杂志(英文版)
关键词 type 1 diabetes diabetic nephropathy Panax notoginoside type 1 diabetes diabetic nephropathy Panax notoginoside
  • 相关文献

参考文献1

二级参考文献10

共引文献2

同被引文献44

引证文献6

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部